Search by...
-
3JunPAD, how to certify digital procurement platformsLa vendita di farmaci online comporta il trattamento di dati personali che possono essere qualificati come dati sulla salute secondo il GDPR, richiedendo specifiche cautele e obblighi per gli operatori del settore
-
-
16SepPAD, how to certify digital procurement platformsCome affrontare l’iter di certificazione delle PAD, le piattaforme di approvvigionamento digitali: ecco una guida completa con tutte le indicazioni per non sbagliare
-
-
2JulAI and healthcare: A question of responsibility and liabilityArtificial intelligence (AI) systems of varying levels of sophistication are increasingly used in health care in conjunction with various medical services.
-
-
6MayHow Digital Procurement Platforms (PADs) change procurementAmong the main types of infrastructure needed to achieve full digitization of public procurement are Digital Procurement Platforms, or “PADs.” On January 1, 2024, the provisions of the new Public Procurement Code on the digitization of tender procedures became fully effective.
-
-
9AprChatbots and virtual assistants: How might they be used in pharmaceuticals?The pharmaceutical sector is not immune to the paradigm shift in user/patient relations, connected to the development and implementation of artificial intelligence systems: when browsing the web and using smartphone applications, users increasingly encounter chatbots and virtual assistants that interact with them.
-
-
16FebDigital tenders and automated procedures: New rules for public procurementThe digitization of tendering procedures is one of the most important issues addressed by the new Public Procurement Code, which systematically reorganizes and significantly changes the rules on the subject.
-
-
11JanDoctors and the use of social media and electronic communication systems: The new FNOMCeO recommendationsFNOMCeO presented a set of Recommendations for the use of social media, e-mail, and instant messaging in the medical setting and in physician-patient communication, to prevent the potential negative repercussions of improper use of these tools.
-
-
22DecArtificial intelligence and health care: News and issues in light of guidance from the Italian Data Protection Authority and the WHOThe use of AI in the healthcare field raises numerous issues. AI is promising and could facilitate improvement of treatment and prevention, and result in more effective allocation of resources in the field. However, there is trepidation about the consequences of possible errors and incorrect use.
-
-
23OctDrug advertising: New rules on advertising for over-the-counter and non-prescription medicines (OTC and SOP)The Italian Ministry of Health updated the guidelines regulating the use of media to publish advertising messages regarding OTC and SOP: a good step in terms of streamlining and simplification of the applicable regulatory framework. Thanks to Denise Moretti for collaborating on this article
-
-
28JunDati anonimi e pseudonimi: cosa cambia per la ricerca dopo l’ultima sentenza della Corte UeIl Tribunale dell’Unione Europea si è espresso di recente sul tema della distinzione fra dati anonimi e pseudonimi. Il significato e l’impatto della sentenza sulla ricerca in ambito medico-scientifico
-
